Director Declaration
9 November 2023 15:00 BST Director Declaration AstraZeneca PLC (the Company) today announced that Philip Broadley,senior independent Non-Executive Directorof the Company, has been appointed as Non-Executive Director and Chair designate to the Board of Lancashire Holdings Limitedwith effect from 8 November 2023.This announcement is made pursuant to Listing Rule 9.6.14 R (2).AstraZenecaAstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare